Drawing for BETR

USPTO serial 90394086

BETR

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
THOMPSON, HEATHER
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BETR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JOHN PAUL OLEKSIUK

JOHN PAUL OLEKSIUK COOLEY LLP1299 PENNSYLVANIA AVENUE NW SUITE 700WASHINGTON, DC 20004UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Antihistamines; Antihistamine blockers; Non-sedating antihistamines; Intra-nasal steroids; bronchodilators; Steroids; Laxatives; Probiotics; Acid reducer; Antacid; Caffeine; Caffeine preparations for stimulative use; Highly caffeinated energy pills; Caffeine preparation for stimulative use in the form of chewing gum; H2 blocker; Proton pump inhibitor; Diphenhydramine; Doxylamine; Melatonin; Nicotine gum for use as an aid to stop smoking; Nicotine patches for use as aids to stop smoking; Nicotine for nicotine replacement therapy; Smoking cessation preparations; Oral spray for cessation of smoking; Transdermal patches featuring smoking cessation preparations; Therapeutic preparations for treating muscle soreness; Topical pain relief products; Medicaments for promoting recovery from tendon and muscle injuries and disorders and sports related injuries Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Analgesic and muscle relaxant pharmaceutical preparations; Topical analgesic creams; Analgesic balm; Analgesic preparations; Topical analgesics; Antipyretic analgesics; Analgesics; Anti-inflammatory salves; Anti-inflammatory gels; Homeopathic anti-inflammatory ointment; Anti-inflammatory and antipyretic preparations; Anti-inflammatory ointments; Anti-inflammatories; Anti-inflammatory sprays; Sports cream for relief of pain; Ibuprofen for use as an oral analgesic; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Oral analgesics; Cough pastilles for medical use; Non-medicated topical gel for the prevention and treatment of cold and flu; Pharmaceutical antitussive-cold preparations; Preparations for treating colds; Anti-cough drop; Cough treatment preparations; Cough syrups; Cough lozenges; Cough expectorants; Cough drops; Medicines, remedies and preparations, namely, antitussive cold preparations, preparations for treating colds, cough treatment preparations in the nature of cough suppressants, cough syrups; cold capsules; flu medicine; day and night cold medicine; pain relievers, namely, aspirin and non-aspirin; sore throat lozenges; external medication for the relief of cold symptoms; pain relief medication; Acetaminophen for relief of pain; Throat powder for the relief of sore throat pain; Preparation for the relief of painACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 10, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 10, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 6, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 28, 2022TMBNTTAB RELEASE CASE TO TRADEMARKS
Jul 28, 2022OP.TOPPOSITION TERMINATED NO. 999999
Jul 28, 2022OP.DOPPOSITION DISMISSED NO. 999999
Mar 9, 2022OP.IOPPOSITION INSTITUTED NO. 999999
Mar 9, 2022OPPFOPPOSITION PAPERS RECEIVED AT TTAB
Feb 8, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 8, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 19, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 4, 2022PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 4, 2022ALIEASSIGNED TO LIE
Jan 3, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 28, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 28, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 28, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 15, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 15, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 15, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 15, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 14, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 17, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2021DOCKASSIGNED TO EXAMINER
Mar 3, 2021MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 2, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2020NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance